Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica · Delayed Price · Currency is JMD 2.750
0.00 (0.00%)
At close: Jul 24, 2026
Indies Pharma Jamaica Financials Overview
Financials in millions JMD. Fiscal year is November - October.
Millions JMD. Fiscal year is Nov - Oct.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Revenue Revenue Growth | 1,095 | 1,126 | 1,159 | 1,055 | 937.28 | 846.83 |
Revenue Growth | -7.49% | -2.82% | 9.81% | 12.61% | 10.68% | 10.56% |
Gross Profit Gross Profit Growth | 640.6 | 668.56 | 693.15 | 638.05 | 613.84 | 517.02 |
Operating Income Operating Income Growth | 221.93 | 263.27 | 283.15 | 270.24 | 281.71 | 217.41 |
Net Income Net Income Growth | 127.86 | 181.29 | 221.18 | 213.06 | 220.79 | 167.87 |
Earnings Per Share EPS Growth | 0.10 | 0.14 | 0.17 | 0.16 | 0.17 | 0.13 |
EPS Growth | -43.58% | -18.04% | 3.81% | -3.50% | 31.53% | -19.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Cash & Investments Cash & Investments Growth | 450.74 | 421.7 | 221.97 | 256.68 | 234.63 | 187.74 |
Total Debt Total Debt Growth | 1,208 | 1,015 | 854.99 | 902.1 | 815.33 | 855.02 |
Net Cash (Debt) Net Cash Growth | -756.95 | -592.81 | -633.02 | -645.42 | -580.7 | -667.27 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.57 | -0.44 | -0.48 | -0.48 | -0.44 | -0.50 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 265.35 | 363.81 | 250.01 | 279.47 | 315.22 | 366.48 |
Capital Expenditures CapEx Growth | -5.78 | -43.52 | -8.88 | -14.02 | -26.37 | -40.72 |
Free Cash Flow Free Cash Flow Growth | 259.56 | 320.3 | 241.13 | 265.45 | 288.85 | 325.76 |
Free Cash Flow Growth | -54.72% | 32.83% | -9.16% | -8.10% | -11.33% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Gross Margin | 58.48% | 59.36% | 59.81% | 60.45% | 65.49% | 61.05% |
Operating Margin | 20.26% | 23.37% | 24.43% | 25.60% | 30.06% | 25.67% |
Pretax Margin | 12.65% | 17.79% | 21.72% | 20.62% | 23.56% | 19.82% |
Profit Margin | 11.67% | 16.10% | 19.08% | 20.19% | 23.56% | 19.82% |
FCF Margin | 23.70% | 28.44% | 20.80% | 25.15% | 30.82% | 38.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.135 | 0.135 | 0.110 | 0.110 | 0.113 | 0.110 |
Dividend Per Share Growth | -44.90% | 22.73% | 0% | -2.66% | 2.73% | -21.43% |
Dividend Yield | 4.91% | 4.98% | 3.79% | 3.99% | 4.25% | 3.96% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
PE Ratio | 28.68 | 20.88 | 19.10 | 19.64 | 18.95 | 26.99 |
P/FCF Ratio | 14.12 | 11.82 | 17.52 | 15.76 | 14.49 | 13.91 |
PS Ratio | 3.35 | 3.36 | 3.65 | 3.96 | 4.46 | 5.35 |